Public Charity

INTERNATIONAL SOCIETY FOR PHARMACEUTICAL ENGINEERING INC

INTERNATIONAL SOCIETY FOR PHARMACEUTICAL ENGINEERING INC is a nonprofit organization categorized as Public Charity based in TAMPA, FL. Its most recent IRS filing (2024) reports revenue of $17.3M, expenses of $17.8M, total assets of $16.9M. Imperigo tracks 1 reported grant relationships connected to this organization totaling approximately $30K.

EIN: 592009272 TAMPA, FL Latest filing: 2024
Total Revenue$17.3M
Total Expenses$17.8M
Total Assets$16.9M
Grant Records1
Funding Total$30K
Filing Years2019–2024

Mission

ISPE IS THE GLOBAL INDUSTRY LEADER IN CONNECTING PHARMACEUTICAL KNOWLEDGE TO DELIVER MANUFACTURING AND SUPPLY CHAIN INNOVATION, OPERATIONAL EXCELLENCE, AND REGULATORY INSIGHTS TO ENHANCE INDUSTRY EFFORTS TO DEVELOP, MANUFACTURE AND RELIABLY DELIVER QUALITY MEDICINES TO PATIENTS.

Where $100 goes at International Society for Pharmaceutical Engineering Inc

How International Society for Pharmaceutical Engineering Inc divides every $100 it spends, from its own Form 990 filings, averaged across 7 years.

$100 Programs the work itself
<$1 Management running the organization
$0 Fundraising none reported

No fundraising costs are reported. That often means fundraising runs through a separate affiliated organization that files its own return.

Inside the $100 for programs

$25
Professional development consists primarily of conferences and training courses to keep industry professionals informed of the latest technological and regulatory trends and to help the pharmaceutical manufacturing profession…
25% of program spending
$25
Membership dues include communication of benefits to members, support by member services, and management and oversight of the ispe chapters and affiliates
25% of program spending
$25
Publications include subscriptions and article reprints providing the most up-to-date information on the latest technological and regulatory trends in the pharmaceutical manufacturing industry
25% of program spending

Plus 1 more program. Cost per person served and the full program breakdown are on the full profile.

Share on LinkedIn Share on Facebook
Add this to your website

Source: Form 990 filings with the IRS, latest fiscal year 2024. Shares are from the organization's reported expenses. Data by Imperigo; not affiliated with the IRS.

Officers & Directors

SR. DIRECTOR, BUSINESS DEVELOPMENT Clifton Dunham
DIRECTOR David Churchward
DIRECTOR Georg Singewald Phd
DIRECTOR (OUTGOING 2024) Hirofumi Suzuki
DIRECTOR (INCOMING 2024) James Grunwald
CHAIR Jeff Biskup Pe

Officer compensation and complete director data available with membership.

Top Grant Purposes

Unspecified
$30,000 1 grant

Financial Trends

Year Revenue Expenses Assets
2024 $17.3M $17.8M $16.9M
2023 $18.3M $17.1M $18.0M
2022 $15.1M $13.5M $16.3M
2020 $9.6M $9.9M $10.7M
2019 $14.2M $13.6M $12.4M

Between 2019 and 2024, reported annual revenue grew from $14.2M to $17.3M (+22%), with total assets most recently reported at $16.9M.

Interactive year-over-year charts and full filing details available with membership.

See the full picture for INTERNATIONAL SOCIETY FOR PHARMACEUTICAL ENGINEERING INC

Complete financials, all 1 grant records, officer compensation, year-over-year trend charts, a geographic grant map, and data exports — across 880,000+ organizations.

Full Financial History Complete Grant Activity Officer Compensation Year-over-Year Charts Geographic Grant Map Data Exports
7-day free trial Cancel any time